Quantum-Si (NASDAQ:QSI) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Quantum-Si (NASDAQ:QSIFree Report) in a research note published on Wednesday,Benzinga reports. HC Wainwright currently has a $4.00 price objective on the stock.

Separately, Canaccord Genuity Group decreased their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday.

Read Our Latest Analysis on QSI

Quantum-Si Price Performance

Shares of QSI stock opened at $0.73 on Wednesday. Quantum-Si has a fifty-two week low of $0.70 and a fifty-two week high of $2.43. The stock’s 50-day moving average is $0.85 and its two-hundred day moving average is $1.10. The firm has a market cap of $104.54 million, a P/E ratio of -1.15 and a beta of 2.89.

Institutional Investors Weigh In On Quantum-Si

A number of large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its position in Quantum-Si by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after buying an additional 145,091 shares during the period. Barclays PLC raised its stake in Quantum-Si by 210.5% during the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after purchasing an additional 133,438 shares during the last quarter. XTX Topco Ltd grew its position in Quantum-Si by 81.3% in the 3rd quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock worth $39,000 after purchasing an additional 19,651 shares during the last quarter. Green Alpha Advisors LLC increased its holdings in shares of Quantum-Si by 35.4% during the 3rd quarter. Green Alpha Advisors LLC now owns 175,055 shares of the company’s stock worth $154,000 after purchasing an additional 45,796 shares during the period. Finally, SG Americas Securities LLC bought a new stake in shares of Quantum-Si in the third quarter valued at about $53,000. Institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

Featured Articles

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.